Literature DB >> 9119221

Identification of redox/repair protein Ref-1 as a potent activator of p53.

L Jayaraman1, K G Murthy, C Zhu, T Curran, S Xanthoudakis, C Prives.   

Abstract

p53 can be isolated from cells in a form that is inert for binding to DNA but that can be stimulated dramatically by phosphorylation, antibody binding, or short single strands of DNA. This suggests that upon genotoxic stress, cells can convert latent p53 to one that is active for DNA binding. Surprisingly, we observed that latent p53 is as effective in activating transcription in vitro as is active p53. We found that HeLa nuclear extracts can stimulate DNA binding by latent p53 and have purified from them a p53-stimulating protein that we have determined to be the product of the Ref-1 gene. Interestingly, Ref-1 is a dual function protein that can both regulate the redox state of a number of proteins and function as a DNA repair (A/P) endonuclease. We observed that oxidized forms of full-length and carboxy-terminally truncated p53 (p53 delta30), which are inactive for DNA binding, are both stimulated by the Ref-1 protein. However, in the presence of reducing agent, Ref-1 is an extremely potent stimulator of full-length p53 but not p53 delta30. These and additional data indicate that Ref-1 protein stimulates p53 by both redox-dependent and -independent means and imply a key role for it in p53 regulation. Importantly, we have also determined that Ref-1 can stimulate p53 transactivation in vivo. This is the first example of a noncovalent protein modifier of p53 function identified in cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119221     DOI: 10.1101/gad.11.5.558

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  116 in total

Review 1.  The molecular basis of asbestos induced lung injury.

Authors:  D W Kamp; S A Weitzman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

2.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

3.  Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.

Authors:  Y Nie; H H Li; C M Bula; X Liu
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  Functional characterization of Ape1 variants identified in the human population.

Authors:  M Z Hadi; M A Coleman; K Fidelis; H W Mohrenweiser; D M Wilson
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

Review 5.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

6.  Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases.

Authors:  Deepa Subramanian; Jack D Griffith
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

7.  Replication of damaged DNA in vitro is blocked by p53.

Authors:  Jianmin Zhou; Carol Prives
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

8.  Attachment of the ubiquitin-related protein Urm1p to the antioxidant protein Ahp1p.

Authors:  April S Goehring; David M Rivers; George F Sprague
Journal:  Eukaryot Cell       Date:  2003-10

Review 9.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

10.  Interactions of apurinic/apyrimidinic endonuclease with a redox inhibitor: evidence for an alternate conformation of the enzyme.

Authors:  Dian Su; Sarah Delaplane; Meihua Luo; Don L Rempel; Bich Vu; Mark R Kelley; Michael L Gross; Millie M Georgiadis
Journal:  Biochemistry       Date:  2010-12-08       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.